Expand the Network

With $161.3 million over the next five years, NIH plans to expand the Pharmacogenomics Research Network, the agency reports. The network had been working on linking genetic variants to cancer, heart disease, asthma, and among others and now will also include research into rheumatoid arthritis and bipolar disorder. The new awards include 14 research grants, with projects ranging from pharmacogenomics in rural areas ranging to the pharmacogenomics of mood stabilizers, as well as seven resource awards.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.